STOCK TITAN

Express Scripts Names Head of Independent Pharmacy Affairs to Deepen Partnerships, Expand Access to Care

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
partnership
Rhea-AI Summary
Express Scripts (NYSE: CI) appoints Dr. Stephanie Smith Cooney as Senior Director of Independent Pharmacy Affairs to lead the industry's first Independent Pharmacy Advisory Committee. Cooney will expand the IndependentRx Initiative, supporting independent pharmacists and driving competitive reimbursement practices. She aims to leverage independent pharmacists to alleviate provider shortages across the health care delivery system.
Positive
  • Dr. Stephanie Smith Cooney's appointment as Senior Director of Independent Pharmacy Affairs will strengthen Express Scripts' support for independent pharmacists, potentially leading to improved patient care and lower costs.
Negative
  • None.
  • Dr. Stephanie Smith Cooney will establish Express Scripts' Office of Independent Pharmacy Enablement and lead the industry's first Independent Pharmacy Advisory Committee 

ST. LOUIS, Aug. 8, 2023 /PRNewswire/ -- Express Scripts, the pharmacy benefits management (PBM) business of The Cigna Group's (NYSE: CI) Evernorth, today named Stephanie Smith Cooney, Pharm.D., as the new Senior Director of Independent Pharmacy Affairs.

"Stephanie is an excellent pharmacist and a proven agent-of-change, helping independent pharmacies reimagine their operations and support patients in new ways," said Adam Kautzner, Pharm.D, President of Express Scripts. "Her unique perspective and experience will help strengthen these relationships and help grow our many efforts underway."

Building on Express Scripts' IndependentRx Initiative announced earlier this year, Cooney will expand the company's efforts to support the important role independent pharmacists play as a front line of care in many local communities. By expanding pharmacy benefits and increasing access to a range of preventive care services at the pharmacy counter, patients will benefit through lower costs and added convenience.

Additionally, she will lead the newly established Independent Pharmacy Advisory Committee, which will convene a diverse group of pharmacy leaders across rural, urban and suburban areas. The advisory committee will focus on continuing to drive competitive reimbursement practices, learning from each other's business models, and creating new solutions that leverage independent pharmacists to alleviate provider shortages across the health care delivery system. 

"I am excited to bring my community pharmacy background to Express Scripts as we work together with independent pharmacies providing critical care and access to patients," said Cooney. "Collaboration and innovation will be key parts of our success moving forward. I look forward to partnering with independent pharmacists in this new role."

As an independent pharmacist for nearly 20 years, Cooney has a track record of leading and managing an innovative community pharmacy. She most recently acted as strategic consultant for independent pharmacy leaders and owners to improve operations and develop innovations. Cooney is also a graduate of the Nesbitt School of Pharmacy at Wilkes University.

About Evernorth Health Services
Evernorth Health Services creates pharmacy, care and benefits solutions to improve health and increase vitality. We relentlessly innovate to make the prediction, prevention and treatment of illness and disease more accessible to millions of people. Evernorth capabilities are powered by our businesses, including Express Scripts, Express Scripts® Pharmacy, Accredo, eviCore and MDLIVE, along with holistic Evernorth platforms and solutions that move people and organizations forward. All Evernorth solutions are serviced and provided by or through operating affiliates of Evernorth Health, a wholly owned subsidiary of The Cigna Group (NYSE: CI), or third-party partners. Learn more at evernorth.com

CONTACT:
Kelly Mathews
media@evernorth.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/express-scripts-names-head-of-independent-pharmacy-affairs-to-deepen-partnerships-expand-access-to-care-301895441.html

SOURCE Express Scripts

FAQ

What is the purpose of Dr. Stephanie Smith Cooney's appointment at Express Scripts (NYSE: CI)?

Dr. Stephanie Smith Cooney is appointed as the Senior Director of Independent Pharmacy Affairs to lead the industry's first Independent Pharmacy Advisory Committee and expand the IndependentRx Initiative.

What is the goal of the Independent Pharmacy Advisory Committee?

The committee aims to drive competitive reimbursement practices, learn from each other's business models, and create new solutions to alleviate provider shortages across the health care delivery system.

What is Dr. Stephanie Smith Cooney's background?

Dr. Stephanie Smith Cooney has nearly 20 years of experience as an independent pharmacist and has previously acted as a strategic consultant for independent pharmacy leaders and owners.

What is the potential impact of this appointment on patient care and costs?

The appointment may lead to improved patient care and lower costs by expanding pharmacy benefits and increasing access to preventive care services at the pharmacy counter.

The Cigna Group

NYSE:CI

CI Rankings

CI Latest News

CI Stock Data

87.68B
278.15M
1.57%
89.11%
1.02%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
BLOOMFIELD